Budget 2026: Pharma, med-tech companies seek PLI extension to cover APIs

The industry expects the government to address these issues in the Union budget announcement this year. Sudarshan Jain, secretary general of Indian Pharmaceutical Alliance (IPA) said the recent global challenges like US tariffs, supply chain disruptions and geopolitical uncertainty have underscored the need for strategic support, and hence, restoring 200% weighted deduction for research and development expenditures would be a significant step.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OqjgdAW
via IFTTT